BiomX Inc.
PHGE
$0.52
-$0.03-5.47%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.85M | 11.74M | 14.25M | 15.08M | 15.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.46M | 30.92M | 33.11M | 35.10M | 37.26M |
| Operating Income | -24.46M | -30.92M | -33.11M | -35.10M | -37.26M |
| Income Before Tax | -47.67M | -36.19M | -37.37M | -18.56M | -8.05M |
| Income Tax Expenses | 6.00K | 7.00K | 9.00K | 6.00K | 9.00K |
| Earnings from Continuing Operations | -47.68 | -36.20 | -37.38 | -18.57 | -8.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.68M | -36.20M | -37.38M | -18.57M | -8.06M |
| EBIT | -24.46M | -30.92M | -33.11M | -35.10M | -37.26M |
| EBITDA | -21.04M | -28.00M | -30.42M | -33.33M | -35.45M |
| EPS Basic | -23.26 | -22.18 | -27.35 | -15.92 | 2.26 |
| Normalized Basic EPS | -11.67 | -10.56 | -12.36 | -1.32 | 5.29 |
| EPS Diluted | -23.26 | -22.18 | -28.78 | -17.35 | -48.03 |
| Normalized Diluted EPS | -11.67 | -10.56 | -12.36 | -1.32 | 3.05 |
| Average Basic Shares Outstanding | 7.90M | 6.52M | 5.74M | 4.95M | 3.68M |
| Average Diluted Shares Outstanding | 7.90M | 6.52M | 5.74M | 4.95M | 4.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |